Examination Report |
1 | TM-1 | 11 Jun 2012 |
10 | Journal Copy | 18 Apr 2018 |
11 | Certificate | 13 Jul 2018 |
12 | TM-R(RENEWAL WITH SURCHARGE) | 29 Nov 2022 |
2 | Power of Attorney | 11 Jun 2012 |
3 | Additional Representation Sheet | 11 Jun 2012 |
4 | Power of Attorney | 07 Oct 2014 |
5 | TM-16 | 07 Oct 2014 |
6 | Reply to Exam Report (MIS-R) | 10 Dec 2014 |
7 | Affidavit | 10 Dec 2014 |
8 | TM-16 | 15 Mar 2016 |
9 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 12 Feb 2018 |
1 | Hearing Notice (Show Cause) | 5164066 | 28 Sep 2017 | |
2 | Hearing Notice (Adjourned) | 5508057 | 2365063 | 05 Dec 2017 |
3 | Hearing Notice (Adjourned) | 5686872 | 2443483 | 10 Jan 2018 |
4 | Tribunal Accepted Notice for : 2346277 | 5887661 | 2526621 | 13 Feb 2018 |
5 | O3 NOTICE | 13147360 | 5546140 | 08 Mar 2022 |
6 | RENEWAL INTIMATION LETTER | 14425501 | 02 Dec 2022 |
Asteride was applied on 11 June 2012.
Trademark application was filed by DR.REDDYS LABORATORIES.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Registered.
Listed application Id of Asteride is 2346277.
Asteride is a WORD as per IP India data.